These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19705087)

  • 1. Antigenic structure of the human muscle nicotinic acetylcholine receptor main immunogenic region.
    Luo J; Lindstrom J
    J Mol Neurosci; 2010 Jan; 40(1-2):217-20. PubMed ID: 19705087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.
    Luo J; Taylor P; Losen M; de Baets MH; Shelton GD; Lindstrom J
    J Neurosci; 2009 Nov; 29(44):13898-908. PubMed ID: 19890000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains.
    Lindstrom J; Luo J; Kuryatov A
    Ann N Y Acad Sci; 2008; 1132():29-41. PubMed ID: 18567851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between the epsilon and gamma subunits of the acetylcholine receptor (AChR) may be significant in autoimmune myasthenia gravis.
    Ragheb S; Lisak RP
    Ann N Y Acad Sci; 2003 Sep; 998():336-8. PubMed ID: 14592892
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-dimensional location of the main immunogenic region of the acetylcholine receptor.
    Beroukhim R; Unwin N
    Neuron; 1995 Aug; 15(2):323-31. PubMed ID: 7544140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
    Schönbeck S; Chrestel S; Hohlfeld R
    Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy.
    Psaridi-Linardaki L; Trakas N; Mamalaki A; Tzartos SJ
    J Neuroimmunol; 2005 Feb; 159(1-2):183-91. PubMed ID: 15652418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors.
    Luo J; Lindstrom J
    Autoimmunity; 2012 May; 45(3):245-52. PubMed ID: 21950318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor.
    Tzartos SJ; Barkas T; Cung MT; Mamalaki A; Marraud M; Orlewski P; Papanastasiou D; Sakarellos C; Sakarellos-Daitsiotis M; Tsantili P; Tsikaris V
    Immunol Rev; 1998 Jun; 163():89-120. PubMed ID: 9700504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies.
    Fostieri E; Tzartos SJ; Berrih-Aknin S; Beeson D; Mamalaki A
    Eur J Immunol; 2005 Feb; 35(2):632-43. PubMed ID: 15627975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
    Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ganglionic acetylcholine receptor autoantibodies.
    Vernino S; Lindstrom J; Hopkins S; Wang Z; Low PA;
    J Neuroimmunol; 2008 Jun; 197(1):63-9. PubMed ID: 18485491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
    Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a highly antigenic and native-like folded extracellular domain of the human α1 subunit of muscle nicotinic acetylcholine receptor, suitable for use in antigen specific therapies for Myasthenia Gravis.
    Niarchos A; Zouridakis M; Douris V; Georgostathi A; Kalamida D; Sotiriadis A; Poulas K; Iatrou K; Tzartos SJ
    PLoS One; 2013; 8(12):e84791. PubMed ID: 24376846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.
    Makino T; Nakamura R; Terakawa M; Muneoka S; Nagahira K; Nagane Y; Yamate J; Motomura M; Utsugisawa K
    PLoS One; 2017; 12(10):e0185976. PubMed ID: 29040265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral pathogenesis of myasthenia gravis.
    Drachman DB; de Silva S; Ramsay D; Pestronk A
    Ann N Y Acad Sci; 1987; 505():90-105. PubMed ID: 2446560
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets.
    Paz ML; Barrantes FJ
    ACS Chem Neurosci; 2019 May; 10(5):2186-2194. PubMed ID: 30916550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature and Action of Antibodies in Myasthenia Gravis.
    Ruff RL; Lisak RP
    Neurol Clin; 2018 May; 36(2):275-291. PubMed ID: 29655450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.